Metraipolis › archive › dc_d7e7bddda0dc

Continuation vs Switching Direct Oral Anticoagulant Therapy After Breakthrough Stroke — Europe PMC PMID:42048077

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42048077
DOI
10.1001/jamanetworkopen.2026.9584
License (as archived)
solo-consultazione
Archived
2026-10-08T09:10:34.646Z
SHA-256 of the archived text
d87d346c652c839f5c033202af5038991007de19dbd32403cc8cf9fc7d107008
Stable URL of this page
https://metraipolis.com/documento/dc_d7e7bddda0dc

How to cite

Continuation vs Switching Direct Oral Anticoagulant Therapy After Breakthrough Stroke — Europe PMC PMID:42048077 — Europe PMC (en), https://europepmc.org/article/MED/42048077 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d7e7bddda0dc (Metraipolis archive dc_d7e7bddda0dc, sha256 d87d346c652c839f5c033202af5038991007de19dbd32403cc8cf9fc7d107008)
BibTeX
@misc{dcd7e7bddda0dc,
  title = {Continuation vs Switching Direct Oral Anticoagulant Therapy After Breakthrough Stroke — Europe PMC PMID:42048077},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42048077},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d7e7bddda0dc; sha256 d87d346c652c839f5c033202af5038991007de19dbd32403cc8cf9fc7d107008},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42048077. Agents can read the archived copy with the MCP tool read_document.